<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>49(5)</volume><submitter>Akabane-Nakata M</submitter><funding>Alnylam Pharmaceuticals</funding><pubmed_abstract>We recently reported the synthesis of 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides, which are based on a bicyclo[3.1.0]hexane scaffold. Here, we analyzed RNAi-mediated gene silencing activity in cell culture and demonstrated that a single incorporation of 2'-F-NMC within the guide or passenger strand of the tri-N-acetylgalactosamine-conjugated siRNA targeting mouse Ttr was generally well tolerated. Exceptions were incorporation of 2'-F-NMC into the guide strand at positions 1 and 2, which resulted in a loss of the in vitro activity. Activity at position 1 was recovered when the guide strand was modified with a 5' phosphate, suggesting that the 2'-F-NMC is a poor substrate for 5' kinases. In mice, the 2'-F-NMC-modified siRNAs had comparable RNAi potencies to the parent </pubmed_abstract><journal>Nucleic acids research</journal><pagination>2435-2449</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7969009</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>siRNAs containing 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2'-F-NMC NTPs.</pubmed_title><pmcid>PMC7969009</pmcid><pubmed_authors>Akabane-Nakata M</pubmed_authors><pubmed_authors>Erande ND</pubmed_authors><pubmed_authors>Janas MM</pubmed_authors><pubmed_authors>Mendez M</pubmed_authors><pubmed_authors>Matsuda S</pubmed_authors><pubmed_authors>Qin J</pubmed_authors><pubmed_authors>Woods LB</pubmed_authors><pubmed_authors>Kumar P</pubmed_authors><pubmed_authors>Gilbert JA</pubmed_authors><pubmed_authors>Jiang Y</pubmed_authors><pubmed_authors>Egli M</pubmed_authors><pubmed_authors>Schlegel MK</pubmed_authors><pubmed_authors>O'Flaherty DK</pubmed_authors><pubmed_authors>Manoharan M</pubmed_authors><pubmed_authors>Degaonkar R</pubmed_authors><pubmed_authors>Zlatev I</pubmed_authors></additional><is_claimable>false</is_claimable><name>siRNAs containing 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides: in vitro and in vivo RNAi activity and inability of mitochondrial polymerases to incorporate 2'-F-NMC NTPs.</name><description>We recently reported the synthesis of 2'-fluorinated Northern-methanocarbacyclic (2'-F-NMC) nucleotides, which are based on a bicyclo[3.1.0]hexane scaffold. Here, we analyzed RNAi-mediated gene silencing activity in cell culture and demonstrated that a single incorporation of 2'-F-NMC within the guide or passenger strand of the tri-N-acetylgalactosamine-conjugated siRNA targeting mouse Ttr was generally well tolerated. Exceptions were incorporation of 2'-F-NMC into the guide strand at positions 1 and 2, which resulted in a loss of the in vitro activity. Activity at position 1 was recovered when the guide strand was modified with a 5' phosphate, suggesting that the 2'-F-NMC is a poor substrate for 5' kinases. In mice, the 2'-F-NMC-modified siRNAs had comparable RNAi potencies to the parent </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2026-05-01T17:25:35.222Z</modification><creation>2024-11-15T01:13:22.124Z</creation></dates><accession>S-EPMC7969009</accession><cross_references><pubmed>33577685</pubmed><doi>10.1093/nar/gkab050</doi></cross_references></HashMap>